Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

BioFocus and Astellas Pharma sign target discovery agreement for CNS disorders

May 13, 2011

Halozyme and ViroPharma sign agreement to develop subcutaneous Cinryze formulation

May 12, 2011

Takeda acquires exclusive rights to fomepizole in Japan from Paladin Labs

May 11, 2011

Allos Therapeutics and Mundipharma to codevelop anticancer drug Folotyn

May 11, 2011

Sosei gains Japanese rights to antifungal agent Loramyc from BioAlliance

May 11, 2011

Albany Medical School and Aegis Therapeutics join to develop peptide against breast cancer

May 11, 2011

Merrimack regains rights to nanoliposomal irinotecan from PharmaEngine

May 10, 2011

TGen licenses selective histone deacetylase inhibitors to Oncoholdings

May 9, 2011

Pfizer returns R-343 rights to Rigel Pharmaceuticals

May 9, 2011

Oxford BioMedica and Pfizer expand licensing agreement for 5T4 antibody

May 6, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...